<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02013960</url>
  </required_header>
  <id_info>
    <org_study_id>0099-13-RMB CTIL</org_study_id>
    <nct_id>NCT02013960</nct_id>
  </id_info>
  <brief_title>Misoprostol vs. Sublingual Misoprostol and Laminaria For Second Trimester Termination of Pregnancy</brief_title>
  <official_title>Comparison Between Sublingual Misoprostol vs. Sublingual Misoprostol and Laminaria For Second Trimester Termination of Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Comparison between the duration of time from the beginning of cervical preparation until
           abortion, between sublingual misoprostol and the combination of sublingual misoprostol
           with laminaria for second trimester medical termination of pregnancy (TOP).

        2. Comparison between the adverse event rate following Sublingual misoprostol only vs.
           Sublingual misoprostol and laminaria given for pregnancy termination.

        3. Comparison between the levels of satisfaction rate of women who underwent pregnancy
           termination with sublingual misoprostol vs. sublingual misoprostol with laminaria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized control trial; 50 women undergoing pregnancy termination in the
      second trimester (14-28 weeks)in each group.

      Following receiving an ethical approval by the local institutional review board (IRB),
      committee, consecutively all women in between 14 weeks to 28 weeks; that have a reason for
      termination of pregnancy like: intrauterine fetal death or medical or genetic indications for
      termination of pregnancy or socioeconomic termination of pregnancy will be offered to take
      part in the study. If eligible according to the inclusion and exclusion criteria, women will
      be asked to sign a consent form.

      All participants will undergo blood exams (CBC, Prothrombin time, Partial thromboplastin time
      , and BLOOD TYPING) and ultrasound exam for Confirmation of diagnosis as routinely indicated
      for missed abortion at our department
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of time until pregnancy termination</measure>
    <time_frame>Average time 12 hours</time_frame>
    <description>From the time of receiving the treatment until complete abortion</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Other Abortion</condition>
  <arm_group>
    <arm_group_label>Laminaria</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cytotec and laminaria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cytotec</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cytotec only</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cytotec</intervention_name>
    <description>Cytotec medication compared with cytotec and laminaria</description>
    <arm_group_label>Laminaria</arm_group_label>
    <arm_group_label>Cytotec</arm_group_label>
    <other_name>Misorpristol vs. Misopristol and laimnria</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Second trimester pregnancy No evidence of chorioamnionitis

        Exclusion Criteria:

        Allergy to misoprostol. Evidence for infection. Asthma
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nibal Awad, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rambam Health Campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2013</study_first_submitted>
  <study_first_submitted_qc>December 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2013</study_first_posted>
  <last_update_submitted>December 11, 2013</last_update_submitted>
  <last_update_submitted_qc>December 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Awad Nibal MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

